NZ551272A - Benzoxazine for treating respiratory tract diseases - Google Patents

Benzoxazine for treating respiratory tract diseases

Info

Publication number
NZ551272A
NZ551272A NZ551272A NZ55127205A NZ551272A NZ 551272 A NZ551272 A NZ 551272A NZ 551272 A NZ551272 A NZ 551272A NZ 55127205 A NZ55127205 A NZ 55127205A NZ 551272 A NZ551272 A NZ 551272A
Authority
NZ
New Zealand
Prior art keywords
hydroxy
ethyl
dimethyl
phenyl
formula
Prior art date
Application number
NZ551272A
Other languages
English (en)
Inventor
Thierry Bouyssou
Ingo Konetzki
Sabine Pestel
Andreas Schnapp
Christoph Hoenke
Philipp Lustenberger
Klaus Rudolf
Kurt Schromm
Frank Buettner
Claudia Heine
Hermann Schollenberger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NZ551272A publication Critical patent/NZ551272A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ551272A 2004-04-22 2005-04-18 Benzoxazine for treating respiratory tract diseases NZ551272A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
PCT/EP2005/004075 WO2005102350A1 (de) 2004-04-22 2005-04-18 Benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
NZ551272A true NZ551272A (en) 2010-10-29

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ551272A NZ551272A (en) 2004-04-22 2005-04-18 Benzoxazine for treating respiratory tract diseases

Country Status (20)

Country Link
EP (1) EP1765355B1 (de)
JP (1) JP2007533684A (de)
KR (2) KR20130042662A (de)
CN (1) CN1946406A (de)
AU (1) AU2005235420C1 (de)
BR (1) BRPI0510084A (de)
CA (1) CA2559700C (de)
DE (1) DE102004019539A1 (de)
DK (1) DK1765355T3 (de)
EA (1) EA012045B1 (de)
EC (1) ECSP066948A (de)
ES (1) ES2403184T3 (de)
IL (1) IL177663A (de)
NO (1) NO20065061L (de)
NZ (1) NZ551272A (de)
PL (1) PL1765355T3 (de)
SG (1) SG152233A1 (de)
UA (1) UA85707C2 (de)
WO (1) WO2005102350A1 (de)
ZA (1) ZA200606547B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
JP5270343B2 (ja) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
WO2007054498A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
WO2009087224A1 (en) 2008-01-11 2009-07-16 Novartis Ag Pyrimidines as kinase inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
MA34969B1 (fr) 2011-02-25 2014-03-01 Irm Llc Composes et compositions en tant qu inibiteurs de trk
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN110062625A (zh) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
AU2005235420C1 (en) 2011-02-24
EP1765355A1 (de) 2007-03-28
EA200601837A1 (ru) 2007-04-27
DE102004019539A1 (de) 2005-11-10
IL177663A0 (en) 2006-12-31
EA012045B1 (ru) 2009-08-28
KR20130042662A (ko) 2013-04-26
AU2005235420B2 (en) 2010-10-28
BRPI0510084A (pt) 2007-10-16
UA85707C2 (ru) 2009-02-25
CA2559700C (en) 2013-06-11
CA2559700A1 (en) 2005-11-03
DK1765355T3 (da) 2013-04-08
KR101338947B1 (ko) 2013-12-10
KR20070054599A (ko) 2007-05-29
PL1765355T3 (pl) 2013-08-30
EP1765355B1 (de) 2013-03-06
SG152233A1 (en) 2009-05-29
IL177663A (en) 2014-04-30
ES2403184T3 (es) 2013-05-16
WO2005102350A1 (de) 2005-11-03
ECSP066948A (es) 2006-12-20
AU2005235420A1 (en) 2005-11-03
NO20065061L (no) 2006-11-07
ZA200606547B (en) 2008-04-30
CN1946406A (zh) 2007-04-11
JP2007533684A (ja) 2007-11-22

Similar Documents

Publication Publication Date Title
AU2005235420C1 (en) Benzoxazine for treating respiratory tract diseases
CA2506082C (en) Novel medicaments for the treatment of chronic obstructive pulmonary disease
US7160882B2 (en) Long acting β-2-agonists and their use as medicaments
US7727984B2 (en) Medicaments for the treatment of chronic obstructive pulmonary disease
CA2565243A1 (en) Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
US7307076B2 (en) Beta agonists for the treatment of respiratory diseases
US20090181961A1 (en) Novel medicaments for the treatment of respiratory diseases
US20110053926A1 (en) New Pharmaceutically-Active Compounds for the Treatment of Respiratory Diseases
US7405232B2 (en) Long acting beta-2 agonists and their use as medicaments
US7563806B2 (en) Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
MXPA06010577A (en) Benzoxazine for treating respiratory tract diseases

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 APR 2016 BY DENNEMEYER + CO.

Effective date: 20150318

LAPS Patent lapsed